Root Financial Partners’s Atea Pharmaceuticals AVIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$604 Buy
+116
New +$593 ﹤0.01% 3151
2026
Q2
– Sell
-84
Closed -$452 – 645
2026
Q1
$452 Buy
+84
New +$386 ﹤0.01% 2900

Other funds holding AVIR

Root Financial Partners's AVIR Position: Q3 2026 in Review

Root Financial Partners opened a new position in Atea Pharmaceuticals (AVIR) in Q3 2026: 116 shares worth $604. The stake represents ﹤0.01% of the portfolio and ranks #3151 among its holdings. This is a return to the name: Root Financial Partners previously reported a position in AVIR as recently as Q1 2026.

Root Financial Partners first reported a position in AVIR in Q1 2026 and has held it in 2 quarters since. 127 funds tracked by Wall St. Rank hold AVIR as of Q3 2026.

  • Root Financial Partners held 116 shares of Atea Pharmaceuticals worth $604 as of Q3 2026.
  • Atea Pharmaceuticals was a new Root Financial Partners position in Q3 2026.
  • Atea Pharmaceuticals made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #3151 holding.
  • Root Financial Partners first reported a position in Atea Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 127 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.